Fungal Infections, An Issue of Infectious Disease Clinics of North America, 1st Edition
著者 :
By Luis Ostrosky-Zeichner, MD and Jack Sobel, MD
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidem
...view more
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few.
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few.
著者情報
By Luis Ostrosky-Zeichner, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center and Jack Sobel, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of Medicine
By Luis Ostrosky-Zeichner, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center and Jack Sobel, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of Medicine
https://shop.elsevier.jp/fungal-infections-an-issue-of-infectious-disease-clinics-of-north-america-9780323416504.html302374Fungal Infections, An Issue of Infectious Disease Clinics of North Americahttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323416504.jpg1283515100JPYInStock/Medicine & Surgery/Infectious Disease/eBooks/Medicine/Infectious Disease/eBooks/eBooks/Medicine/Infectious Disease/Medicine/Infectious Disease/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book433514643887245054623505466552550405259860580356059368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828<p>There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few. </p> <p>There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few. </p>00add-to-cart97803234165042016専門医By Luis Ostrosky-Zeichner, MD and Jack Sobel, MD20161E-BookElsevier02016/03/12IN STOCKBy <STRONG>Luis Ostrosky-Zeichner</STRONG>, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center and <STRONG>Jack Sobel</STRONG>, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of MedicineE-BookE-BookThe Clinics: Internal MedicineS013Infectious Disease, Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください